HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER		Author Keyword(s) Vol Page [Advanced]

This Article Full Text Full Text (PDF) Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this link to a friend Similar articles in this journal Similar articles in PubMed Add article to my folders Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Derenzini, M Articles by Treré, D Search for Related Content PubMed PubMed Citation Articles by Derenzini, M Articles by Treré, D Pubmed/NCBI databases Medline Plus Health Information Breast Cancer

The prognostic value of the AgNOR parameter in human breast cancer depends on the pRb and p53 status

¹ Department of Experimental Pathology, Unit of Clinical Pathology, University of Bologna, Bologna 40126, Italy
² Institute of Surgical Pathology, Breast Cancer Unit, S. Orsola–Malpighi Hospital, Bologna 40138, Italy
³ Centre for Applied Biomedical Research, S. Orsola–Malpighi Hospital, Italy
⁴ First Surgical Clinic, Breast Cancer Surgical Unit, S. Orsola–Malpighi Hospital

Correspondence to:
Professor M Derenzini
Alma Mater Studiorum, Università di Bologna, Dipartimento di Patologia Sperimentale, Via San Giacomo 14, 40126 Bologna, Italy; massimo.derenzini{at}unibo.it Background: The amount of argyrophilic nucleolar organiser regions (AgNORs) represents a cell kinetics parameter used in tumour pathology for prognostic purposes. AgNOR expression is directly related to the rate of ribosome biogenesis, which has been recently shown to be controlled also by the tumour suppressor proteins pRb and p53.

Aims: To ascertain the relative prognostic value of AgNORs and of pRb and p53 expression in breast carcinoma.

Methods: This study was carried out on 335 human primary breast carcinomas with a median follow up time of 108 months. AgNORs were measured by morphometric analysis on sections that had been selectively silver stained; expression of p53 and phosphorylated and non-phosphorylated pRb forms was assessed by immunohistochemistry.

Results: Patients were divided into groups with low (249) and high (86) AgNOR values; with normal (267) and mutated p53 (68); and with normal (256) and hyperphosphorylated or deleted pRb (79). Univariate analysis of disease free survival showed that AgNORs and the status of pRb and p53 were significantly related to the patients’ clinical outcome. However, among the four groups characterised by different pRb and p53 status, the AgNOR parameter was not capable of distinguishing subgroups of patients with different clinical outcomes.

Conclusions: These findings indicate that the prognostic value of the AgNOR parameter depends on the status of the tumour suppressor proteins pRb and p53, and it cannot be ascribed to the relation between AgNORs and the cell proliferation rate.

Abbreviations: AgNOR, argyrophilic nucleolar organiser region; DFS, disease free survival; LIa, labelling index area; MoAb, monoclonal antibody; NOR, nucleolar organiser region; UBF, upstream binding factor

Keywords: argyrophilic ucleolar organiser region breast cancer; p53 pRb prognosis

This article has been cited by other articles:

				L. Montanaro, D. Trere, and M. Derenzini Nucleolus, Ribosomes, and Cancer Am. J. Pathol., August 1, 2008; 173(2): 301 - 310. [Abstract] [Full Text] [PDF]

				M. Derenzini, G. Donati, G. Mazzini, L. Montanaro, M. Vici, C. Ceccarelli, D. Santini, M. Taffurelli, and D. Trere Loss of Retinoblastoma Tumor Suppressor Protein Makes Human Breast Cancer Cells More Sensitive to Antimetabolite Exposure Clin. Cancer Res., April 1, 2008; 14(7): 2199 - 2209. [Abstract] [Full Text] [PDF]

				D. Trere, C. Ceccarelli, L. Montanaro, E. Tosti, and M. Derenzini Nucleolar Size and Activity Are Related to pRb and p53 Status in Human Breast Cancer J. Histochem. Cytochem., December 1, 2004; 52(12): 1601 - 1607. [Abstract] [Full Text] [PDF]